Charles River Laboratories International (CRL) News Today $199.06 -0.53 (-0.27%) (As of 11/29/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Bellevue Group AG Decreases Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Bellevue Group AG lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 68.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,115 sharDecember 1 at 7:13 AM | marketbeat.comAmerican Capital Management Inc. Sells 35,500 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)American Capital Management Inc. decreased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 19.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 147,800 shares of the medical resDecember 1 at 6:50 AM | marketbeat.comPDT Partners LLC Sells 3,500 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)PDT Partners LLC lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 27.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,263 shares of the medical research company's stock after selliDecember 1 at 5:46 AM | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Buys Shares of 14,800 Charles River Laboratories International, Inc. (NYSE:CRL)Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 14,800 shDecember 1 at 4:31 AM | marketbeat.comBNP Paribas Financial Markets Sells 48,659 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)BNP Paribas Financial Markets cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 38.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 79,171 shares of the medical research comDecember 1 at 4:13 AM | marketbeat.comQuantbot Technologies LP Purchases Shares of 8,169 Charles River Laboratories International, Inc. (NYSE:CRL)Quantbot Technologies LP acquired a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 8,169 shares of the medical research company's stock,November 30 at 4:30 AM | marketbeat.comThe Manufacturers Life Insurance Company Trims Position in Charles River Laboratories International, Inc. (NYSE:CRL)The Manufacturers Life Insurance Company trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 42.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional inveNovember 30 at 4:16 AM | marketbeat.comAre Wall Street Analysts Predicting Charles River Stock Will Climb or Sink?November 29 at 9:20 AM | msn.comCharles River Laboratories International, Inc. (NYSE:CRL) Position Increased by Financial Counselors Inc.Financial Counselors Inc. lifted its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 22.6% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 26,592 shares of the medical research company's stock after buyNovember 29 at 6:30 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Given Consensus Rating of "Reduce" by BrokeragesNovember 29 at 4:57 AM | americanbankingnews.comFORA Capital LLC Sells 2,961 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)FORA Capital LLC reduced its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 32.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,026 shares of the medical reseNovember 28 at 7:42 AM | marketbeat.comMudita Advisors LLP Decreases Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Mudita Advisors LLP cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 22.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,707 shares of the medical research company's sNovember 27, 2024 | marketbeat.comCharles River Laboratories International Q3 Earnings TranscriptNovember 27, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Purchases 32,311 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Charles Schwab Investment Management Inc. raised its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 6.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 515,222 shares of the medical research coNovember 27, 2024 | marketbeat.comCharles River Laboratories International Inc (CRL)'s Winning Formula: Financial Metrics and ...November 26, 2024 | gurufocus.comHorizon Kinetics Asset Management LLC Sells 45,619 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Horizon Kinetics Asset Management LLC decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 28.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1November 25, 2024 | marketbeat.comCitigroup Inc. Has $46.51 Million Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Citigroup Inc. lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 10.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 236,141 shares of the medical research comNovember 25, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Receives Average Rating of "Reduce" from AnalystsShares of Charles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) have received an average rating of "Reduce" from the fifteen analysts that are presently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation,November 24, 2024 | marketbeat.comBNP PARIBAS ASSET MANAGEMENT Holding S.A. Sells 63,588 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)BNP PARIBAS ASSET MANAGEMENT Holding S.A. lessened its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 30.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional iNovember 23, 2024 | marketbeat.comLathrop Investment Management Corp Cuts Position in Charles River Laboratories International, Inc. (NYSE:CRL)Lathrop Investment Management Corp lessened its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 16.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 25,414 shares of the medical researchNovember 22, 2024 | marketbeat.comKing Luther Capital Management Corp Sells 252,657 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)King Luther Capital Management Corp trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 79.4% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 65,689 shares of the medical reseaNovember 22, 2024 | marketbeat.comBrown Capital Management LLC Has $1.29 Million Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Brown Capital Management LLC trimmed its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 67.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,546 shares of the mNovember 21, 2024 | marketbeat.comPremier Fund Managers Ltd Raises Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Premier Fund Managers Ltd boosted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 56.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 250,000 shares of the medical research compNovember 20, 2024 | marketbeat.comNatixis Advisors LLC Lowers Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Natixis Advisors LLC trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,143 shares of the medicaNovember 20, 2024 | marketbeat.comCharles River Laboratories: Not The Right Time To Own At This Point In The CycleNovember 19, 2024 | seekingalpha.comThrivent Financial for Lutherans Sells 41,997 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Thrivent Financial for Lutherans cut its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 11.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 332,662 shares of the medical researchNovember 19, 2024 | marketbeat.comMawer Investment Management Ltd. Sells 32,693 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Mawer Investment Management Ltd. cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 44.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 40,860 shares of the medicalNovember 18, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Rating Lowered to Underperform at CLSACLSA lowered Charles River Laboratories International from a "hold" rating to an "underperform" rating and set a $164.00 price target on the stock. in a research note on Monday.November 18, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Sumitomo Mitsui Trust Group Inc.Sumitomo Mitsui Trust Group Inc. boosted its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 3.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 111,995 shares of the medical research comNovember 18, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by Mizuho Securities USA LLCMizuho Securities USA LLC lifted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2,336.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 96,871 shares of theNovember 16, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by KBC Group NVKBC Group NV cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 37.3% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 84,566 shares of the medical research coNovember 16, 2024 | marketbeat.comVictory Capital Management Inc. Sells 117,418 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Victory Capital Management Inc. decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 25.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 348,276 shares of the medical research company's stock aNovember 15, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Entropy Technologies LPEntropy Technologies LP decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 51.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,125 shares ofNovember 14, 2024 | marketbeat.comEntropy Technologies LP Trims Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Entropy Technologies LP lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 51.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,125 shareNovember 14, 2024 | marketbeat.comEmpower Advisory Group LLC Sells 3,497 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Empower Advisory Group LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 1.3% in the third quarter, according to its most recent filing with the SEC. The fund owned 269,104 shares of the medical research company's stock after selling 3,November 13, 2024 | marketbeat.comInsider Selling: Charles River Laboratories International, Inc. (NYSE:CRL) Director Sells 6,621 Shares of StockNovember 13, 2024 | insidertrades.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by WCM Investment Management LLCWCM Investment Management LLC grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 33.3% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,367 shares of the medical research company's sNovember 12, 2024 | marketbeat.comAmalgamated Bank Trims Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Amalgamated Bank decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 22.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,121 shares of the medical reseaNovember 12, 2024 | marketbeat.comCharles River price target raised to $227 from $203 at TD CowenNovember 11, 2024 | markets.businessinsider.comCharles River Laboratories International (NYSE:CRL) Price Target Raised to $227.00TD Cowen increased their price target on Charles River Laboratories International from $203.00 to $227.00 and gave the stock a "hold" rating in a research note on Monday.November 11, 2024 | marketbeat.comCharles River Laboratories to Present at UBS and Jefferies ConferencesNovember 11, 2024 | finance.yahoo.comCautious Optimism: Hold Rating for Charles River Labs Amid Mixed Signals and Market UncertaintiesNovember 11, 2024 | markets.businessinsider.comWilliam Blair Analysts Reduce Earnings Estimates for CRLCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - William Blair decreased their Q4 2024 earnings estimates for Charles River Laboratories International in a report issued on Thursday, November 7th. William Blair analyst M. Smock now anticipates that the medical research coNovember 11, 2024 | marketbeat.comJensen Investment Management Inc. Sells 3,730 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Jensen Investment Management Inc. decreased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 23.4% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,180 shares of the medical research company's stockNovember 10, 2024 | marketbeat.comHold Rating for Charles River Labs Amid Mixed Performance and Market UncertaintiesNovember 8, 2024 | markets.businessinsider.comJ.P. Morgan Sticks to Its Hold Rating for Charles River Labs (CRL)November 8, 2024 | markets.businessinsider.comCharles River Laboratories International (NYSE:CRL) Upgraded to Hold at CLSACLSA raised Charles River Laboratories International from an "underperform" rating to a "hold" rating and set a $205.00 price target for the company in a report on Thursday.November 7, 2024 | marketbeat.comEvercore ISI Forecasts Strong Price Appreciation for Charles River Laboratories International (NYSE:CRL) StockEvercore ISI lifted their price target on Charles River Laboratories International from $190.00 to $225.00 and gave the company an "in-line" rating in a research note on Thursday.November 7, 2024 | marketbeat.comVan ECK Associates Corp Sells 6,633 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Van ECK Associates Corp decreased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 11.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 51,273 sharNovember 7, 2024 | marketbeat.comCharles River upgraded to Hold from Underperform at CLSANovember 6, 2024 | markets.businessinsider.com Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] CRL Media Mentions By Week CRL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRL News Sentiment▼1.260.87▲Average Medical News Sentiment CRL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRL Articles This Week▼177▲CRL Articles Average Week Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Agilent Technologies News Mettler-Toledo International News Illumina News Waters News Bio-Techne News Bio-Rad Laboratories News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CRL) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored***TODAY ONLY*** Is this Trump’s Favorite Coin?Donald Trump just emphatically became America's first crypto president. Trump plans to make America, "the...Weiss Ratings | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRL Stock Alerts